Pharmacokinetic and Pharmacodynamic Analysis of the Oxacephem Antibiotic Flomoxef against Extended-Spectrum β-Lactamase-Producing Enterobacterales from Dogs

Pharmacokinetic and Pharmacodynamic Analysis of the Oxacephem Antibiotic Flomoxef against Extended-Spectrum β-Lactamase-Producing Enterobacterales from Dogs

Flomoxef (FMX) may be a potential alternative to carbapenems for dogs infected with Enterobacterales-producing extended-spectrum β-lactamase (ESBL-E). However, the appropriate dosage of FMX in dogs with ESBL-E infections has yet to be established. This study was carried out to establish appropriate...

Full description

Bibliographic Details
Main Authors:	Mizuki Kusumoto, Makoto Jitsuiki, Tomoki Motegi, Kazuki Harada
Format:	Article
Language:	English
Published:	MDPI AG 2024-01-01
Series:	International Journal of Molecular Sciences
Subjects:	pharmacokinetics–pharmacodynamics approach flomoxef extended-spectrum β-lactamases Enterobacterales dogs
Online Access:	https://www.mdpi.com/1422-0067/25/2/1105

Similar Items

Pharmacokinetic/Pharmacodynamic Analysis and Dose Optimization of Cefmetazole and Flomoxef against Extended-Spectrum β-Lactamase-Producing <i>Enterobacterales</i> in Patients with Invasive Urinary Tract Infection Considering Renal Function
by: Yukihiro Hamada, et al.
Published: (2022-03-01)

In vitro pharmacokinetics/pharmacodynamics of FL058 (a novel beta-lactamase inhibitor) combined with meropenem against carbapenemase-producing Enterobacterales
by: Zhiwei Huang, et al.
Published: (2024-04-01)

A multicentre study to determine the in vitro efficacy of flomoxef against extended-spectrum beta-lactamase producing Escherichia coli in Malaysia
by: Polly Soo Xi Yap, et al.
Published: (2023-11-01)

Pharmacokinetic–pharmacodynamic analysis of cefmetazole against extended-spectrum β-lactamase-producing Enterobacteriaceae in dogs using Monte Carlo Simulation
by: Mizuki Kusumoto, et al.
Published: (2023-09-01)

Clinical benefit of ertapenem compared to flomoxef for the treatment of cefotaxime-resistant Enterobacteriaceae bacteremia
by: Lee C, et al.
Published: (2018-02-01)

Pharmacodynamics of Ceftibuten: An Assessment of an Oral Cephalosporin against Enterobacterales in a Neutropenic Murine Thigh Model
by: Maxwell J. Lasko, et al.
Published: (2021-02-01)

Extended spectrum Beta-Lactamase (ESBL) producing Enterobacterales: Classification and resistance genetic background
by: Milić Marija, et al.
Published: (2019-01-01)

Hydroxyhexylitaconic acids as potent IMP-type metallo-β-lactamase inhibitors for controlling carbapenem resistance in Enterobacterales
by: Jun-ichi Wachino, et al.
Published: (2024-03-01)

Antibacterial effect evaluation of moxalactam against extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae with in vitro pharmacokinetics/pharmacodynamics simulation
by: Huang C, et al.
Published: (2018-01-01)

Pharmacokinetic and pharmacodynamic modeling of oral mitiglinide on glucose lowering in healthy Chinese volunteers
by: Shijia Liu, et al.
Published: (2017-07-01)

In Vitro Activity of Auranofin in Combination With Aztreonam-Avibactam Against Metallo-β-lactamase (MBL)-Producing Enterobacterales
by: Wen Wang, et al.
Published: (2021-10-01)

Nosocomial extended-spectrum beta-lactamase-producing Klebsiella pneumoniae bacteremia in hemodialysis patients and the implications for antibiotic therapy
by: Chih-Chao Yang, et al.
Published: (2014-11-01)

Ivermectin: Difficulties in resolving pharmacokinetic and pharmacodynamic relationships in onchocerciasis
by: E N Shu, et al.
Published: (2004-01-01)

Therapeutic Options for Metallo-β-Lactamase-Producing Enterobacterales
by: Tan X, et al.
Published: (2021-01-01)

Pharmacokinetic–Pharmacodynamic Model for the Testosterone-Suppressive Effect of Leuprolide in Normal and Prostate Cancer Rats
by: Dong-Seok Lee, et al.
Published: (2018-04-01)

Pharmacodynamics and pharmacokinetics of nalbuphine in xylazine‑sedated horses
by: Amal Hammad, et al.
Published: (2023-05-01)

Pharmacodynamics of Five Anthraquinones (Aloe-emodin, Emodin, Rhein, Chysophanol, and Physcion) and Reciprocal Pharmacokinetic Interaction in Rats with Cerebral Ischemia
by: Rong-Rong Li, et al.
Published: (2019-05-01)

Pharmacokinetic/Pharmacodynamic Model of Neutropenia in Real-Life Palbociclib-Treated Patients
by: Alexandre Le Marouille, et al.
Published: (2021-10-01)

Concept and utility of population pharmacokinetic and pharmacokinetic/pharmacodynamic models in drug development and clinical practice
by: Roganović Maša, et al.
Published: (2021-01-01)

Tigecycline Pharmacokinetic and Pharmacodynamic Profile in Patients with Chronic Obstructive Pulmonary Disease Exacerbation
by: Maria Kipourou, et al.
Published: (2023-02-01)

Pharmacokinetic/pharmacodynamic comparison between generic and brand-name levofloxacin based on Monte Carlo simulation
by: Pan Ma, et al.
Published: (2023-06-01)

Pharmacokinetics of Non-β-Lactam β-Lactamase Inhibitors
by: Giacomo Luci, et al.
Published: (2021-06-01)

Pharmacokinetic and pharmacodynamic correlation of plasma concentrations and blood pressure in hypertensive patients: A study
by: Mahvash Iram, et al.
Published: (2016-01-01)

Carriage Prevalence of Extended-Spectrum β-Lactamase Producing Enterobacterales in Outpatients Attending Community Health Centers in Blantyre, Malawi
by: Onduru Gervas Onduru, et al.
Published: (2021-09-01)

The Genotypic and Phenotypic Characteristics Contributing to Flomoxef Sensitivity in Clinical Isolates of ESBL-Producing <i>E. coli</i> Strains from Urinary Tract Infections
by: Kazuma Sakaeda, et al.
Published: (2023-03-01)

Characterization of beta-lactamase producing Enterobacterales isolated from an urban community wastewater treatment plant in Iran
by: Kamal Hasani, et al.
Published: (2023-08-01)

Characterization of β-Lactamases and Multidrug Resistance Mechanisms in Enterobacterales from Hospital Effluents and Wastewater Treatment Plant
by: Christopher Mutuku, et al.
Published: (2022-06-01)

Pharmacokinetic and Pharmacodynamic Properties of Rosmarinic Acid in Rat Cholestatic Liver Injury
by: Jianbin Min, et al.
Published: (2018-09-01)

Pharmacodynamics and pharmacokinetics interaction between nefopam and tramadol in the broiler chicks model
by: Yaareb J. Mousa, et al.
Published: (2022-04-01)

Influence of aprepitant on the pharmacodynamics and pharmacokinetics of gliclazide in rats and rabbits
by: Raghunandan Reddy Kura, et al.
Published: (2018-05-01)

Isavuconazole Pharmacokinetics and Pharmacodynamics in Children
by: Hirsh Elhence, et al.
Published: (2022-12-01)

COMPARISON OF PHARMACOKINETICS AND PHARMACODYNAMICS OF THE ORIGINAL AND GENERIC ENALAPRIL IN THE ELDERLY PATIENTS WITH ARTERIAL HYPERTENSION
by: O. P. Bobrova, et al.
Published: (2015-12-01)

MIC profiling of ceftazidime/avibactam against two carbapenemase-producing Klebsiella pneumoniae isolates
by: Andrei Zidaru, et al.
Published: (2020-12-01)

Pharmacokinetic/Pharmacodynamic Adequacy of Novel β-Lactam/β-Lactamase Inhibitors against Gram-Negative Bacterial in Critically Ill Patients
by: Ruiying Han, et al.
Published: (2021-08-01)

Effects of Carbamazepine and Phenytoin on Pharmacokinetics and Pharmacodynamics of Rivaroxaban
by: Lien Thi Ngo, et al.
Published: (2020-10-01)

An Appraisal of the Pharmacokinetic and Pharmacodynamic Properties of Meropenem-Vaborbactam
by: Eric Wenzler, et al.
Published: (2020-10-01)

The pharmacokinetics and pharmacodynamics of fentanyl administered via transdermal patch in horses
by: Rachel A. Reed, et al.
Published: (2024-03-01)

A semi-compartmental model describing the pharmacokinetic-pharmacodynamic relationship
by: Seunghee Ki
Published: (2020-01-01)

Cinnamon modulates the pharmacodynamic & pharmacokinetic of amlodipine in hypertensive rats
by: Ibrahim Abdelsalam Abdelrahman, et al.
Published: (2023-09-01)

The Aspects Which Might Be Taken into Consideration During Antimicrobial Therapy: Pharmacokinetic and Pharmacodynamic Approach
by: Lütfiye EROĞLU
Published: (2000-06-01)